Tuesday, January 6, 2015

Gilead to Buy Phenex's Liver-Disease Program

Gilead Sciences reached a deal to buy a liver-disease treatment program from privately held biotechnology company Phenex Pharmaceuticals.



from WSJ.com: US Business http://ift.tt/1xPMe6T

via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)